Further characterization of myeloid cells revealed that during more severe disease, a subset of Ly6GMid granulocytes (CD19Neg CD11bHigh Ly6GMid GR1Mid Ly6CHigh) became apparent (Fig. 1b). The abundance of these cells increased over time, becoming the prominent Ly6G-expressing cell population in ...